JPRN-UMIN000002941CompletedPhase 4
The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B - The analysis of QOL in the patients of GERD with chronic liver disease after the treatment of PPI or H2-B
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- CHiba University hospital
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients with allergy for sodium rabeprazole and ranitidine hydrochloride The patients with severe live failure The patients treated by Interferon or with malignant tumor
Investigators
Similar Trials
Not yet recruiting
Phase 1
EVALUATION OF GERD IN BARIATRIC PATIENTSCTRI/2024/06/068326Self
Completed
Not Applicable
Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective StudyGERDNCT00697008AstraZeneca300
Completed
Not Applicable
A Study of the Improvement of Symptoms in GERD Patients by Practical Use of Esomeprazole 20mgJPRN-UMIN000018456Ishihara Gastroenterology clini20
Completed
Not Applicable
A clinical study of the correlation between QOL and the effects of oral anti-diabetic drugs on newly treated patients with type2 diabetestype2 diabetesJPRN-UMIN000006986QOL study group for oral anti-diabetic agent800
Recruiting
Not Applicable
Study of CO2 fractional laser treatment for GSMJPRN-jRCTs032210633Tozawa Akiko100